GlassScriptPhysician profile
Ashley Fought
NPI 1558772962
$1,078.78
in general payments reported to CMS, 2019-2025
6 companies · $94.45 in 2025
The $94.45 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.52 · 2023: $92.17 · 2024: $880 · 2025: $94.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $715 · Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $714.57 |
| Food and Beverage | $351.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $714.57 | 2024 | Acell |
| Smith+Nephew, INC. | $154.94 | 2022-2025 | Collagenase Santyl, Acticoat 4" X 4", Iodosorb Ointment 40g USA |
| Eclipse Technology Solutions INC. | $102.54 | 2024 | |
| Organogenesis INC. | $69.49 | 2024-2025 | Apligraf |
| Lifenet Health | $23.14 | 2025 | Theragenesis Wound Matrix |
| Cashflow Solutions, LLC | $14.10 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Fought listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.